pharma · HIV Infections · HIV-1 infection
ViiV Healthcare Pty
ViiV Healthcare Pty Ltd
ViiV Healthcare is a pharma organization headquartered in London, GB. Primary therapeutic focus areas include HIV Infections, HIV-1 infection, Human immunodeficiency virus (HIV), human immunodeficiency virus (HIV). NovaP
London, GB HQ
2009 Founded
1,906 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- London, GB
- Founded
- 2009
- Employees
- 1,906
- Programs
- 10
- Drugs
- 27
- Patents
- 0
Rukobia 600 mg prolonged-release tablets
Phase 3 · small molecule · Heavily Treatment Experienced Subjects Infected with Multi-drug Resistant (MDR) HIV-1
Rukobia 600 mg prolonged-release tablets for Heavily Treatment Experienced Subjects Infected with Multi-drug Resistant (MDR) HIV-1 is a Phase 3 program (small_molecule) at ViiV Healthcare Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code 205888
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ViiV Healthcare Pty Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Heavily Treatment Experienced Subjects Infected with Multi-drug Resistant (MDR) HIV-1
- Status
- active
- Trials
- 1